It’s crickets on ARN threads even though first assays are upcoming in a few days that may see a potential tier 1 Nb/ rare earth discovery.
Ignoring the 2 day almost 40% spike in the SP, the lack of posters and comments on ARN threads suggests retail investors are not aware of ARN’s prospects or are just not interested ie ARN is not on investors radar. One possible explanation is that investors do not understand or are dismissing the potential for a major Nb/REE discovery by ARN.
There are almost no institutional shareholders on ARN’s register and few nominee companies. I am not aware of any coverage of ARN from any brokers/analysts other than a report from Discovery Alert.
The only presentation from ARN was in mid-2024 for the last CR and none for quite a while before that. No public appearances at any conferences for at least 2 years and only a few 5min interviews which are now well over a year old.
ARN has kept an extremely low public profile - well sort of no profile.
My conclusion is that ARN is going so far under the radar that it’s almost invisible to retail and institutional investors.
What does that mean for the SP if the assays are good and alternative great or speculator? In such a situation it is possible that good assays will send the SP up significantly and if they end up with 100m to 250m high grade Nb (ie 1%+) and/or high grade TREO over 100m+ or in other words great or speculator results, it will then be on everyone’s radar and the SP may rise very very significantly over the following week/month.
- Forums
- ASX - By Stock
- ARN
- Ann: Trading Halt
ARN
aldoro resources limited
Add to My Watchlist
0.00%
!
32.0¢

Ann: Trading Halt, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M |
Open | High | Low | Value | Volume |
31.5¢ | 32.0¢ | 31.5¢ | $16.77K | 53.21K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 52387 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 146559 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 52387 | 0.315 |
3 | 9773 | 0.310 |
2 | 37960 | 0.305 |
12 | 65020 | 0.300 |
1 | 50000 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 146559 | 1 |
0.330 | 4341 | 3 |
0.335 | 55998 | 3 |
0.340 | 13432 | 1 |
0.350 | 154 | 1 |
Last trade - 13.06pm 27/06/2025 (20 minute delay) ? |
Featured News
ARN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online